ARTA
FCSC

A.R.T. Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

A.R.T. Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,415
Closed -$52K – 1818
2017
Q3 		$52K Buy
+3,415
New +$55.2K ﹤0.01% 1255
2017
Q2 		– Sell
-2,121
Closed -$21K – 1882
2017
Q1 		$21K Buy
2,121
+335
+19% +$3.72K ﹤0.01% 1373
2016
Q4 		$16K Buy
+1,786
New +$19.2K ﹤0.01% 1250
2016
Q3 		– Sell
-3,803
Closed -$65K – 1390
2016
Q2 		$65K Buy
+3,803
New +$118K ﹤0.01% 1252
2015
Q2 		– Sell
-1,635
Closed -$110K – 1828
2015
Q1 		$110K Buy
+1,635
New +$105K ﹤0.01% 1310

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

A.R.T. Advisors's FCSC Position: Q4 2017 in Review

A.R.T. Advisors sold out of Fibrocell Science Inc. (FCSC) in Q4 2017, closing a stake of 3,415 shares — an estimated $52K sold.

A.R.T. Advisors first reported a position in FCSC in Q1 2015 and held it in 5 quarters. The position peaked at $110K in Q1 2015. 32 funds tracked by Wall St. Rank hold FCSC as of Q4 2017.

  • A.R.T. Advisors reported no remaining Fibrocell Science Inc. position as of Q4 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 3,415 Fibrocell Science Inc. shares in Q4 2017, an estimated $52K.
  • A.R.T. Advisors first reported a position in Fibrocell Science Inc. in Q1 2015 and held it in 5 quarters.
  • A.R.T. Advisors's Fibrocell Science Inc. position peaked at $110K in Q1 2015.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2017.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.